ERAS

ERAS

Target · Small GTPase

ERAS ES cell expressed Ras · GTPase ERas

ERAS (ES cell expressed Ras, also known as HRAS2 or HRASP) is a constitutively active member of the Ras family of small GTPases. It binds GDP and GTP, has intrinsic GTPase activity, and contributes to the tumour-like growth of embryonic stem cells. Browse Assay Genie's current range of ERAS research reagents below, or read on for the biology behind the target.

Cell membrane proteinRas family small GTPaseStem cell PI3K activator
233 aa
Protein length
~25 kDa
Molecular weight
Xp11.23
Gene locus
EC 3.6.5.2
Enzyme class
Target information

What is ERAS (ES cell expressed Ras)?

ERAS is a small GTPase of the Ras family. Like other Ras proteins, it binds GDP and GTP and carries intrinsic GTPase activity. The NCBI Gene summary describes it as constitutively active. UniProt annotates a role in the tumour-like growth properties of embryonic stem cells, and the protein localises to the cell membrane.

According to the NCBI Gene summary, the ERAS protein activates the phosphatidylinositol 3-kinase signal transduction pathway in undifferentiated stem cells. It is not expressed in differentiated cells. This restricted pattern makes the ERAS gene a point of interest for work on stemness and on how stem cell-like growth is maintained.

The gene is named for its expression in embryonic stem (ES) cells. Its previous symbols, HRAS2 and HRASP, and its earlier name, v-Ha-ras Harvey rat sarcoma viral oncogene homolog pseudogene, reflect its similarity to the HRAS gene. HGNC places it in the RAS type GTPase family. UniProt classes the protein in the small GTPase superfamily, Ras family. The gene may be involved in cancer and chemotherapy resistance, so researchers studying ERAS often examine it alongside other Ras signalling components. The mouse ortholog is Eras.

Embryonic stem cell biology

ERAS contributes to the tumour-like growth properties of embryonic stem cells, making it relevant to studies of pluripotency and proliferation.

PI3K pathway signalling

ERAS activates the phosphatidylinositol 3-kinase pathway in undifferentiated stem cells, so it is studied as an upstream regulator of this cascade.

Cancer research

The ERAS gene may be involved in cancer, and its restricted expression pattern invites comparison between undifferentiated and differentiated states.

Chemotherapy resistance studies

NCBI Gene notes a possible role for ERAS in chemotherapy resistance, which makes it a candidate for work on treatment response.

Background

ERAS frequently asked questions

What does ERAS do?

ERAS is a Ras family small GTPase that binds GDP and GTP and has intrinsic GTPase activity. It is constitutively active, activates the phosphatidylinositol 3-kinase pathway in undifferentiated stem cells, and plays an important role in the tumour-like growth properties of embryonic stem cells.

What other names does ERAS go by?

ERAS stands for ES cell expressed Ras, and UniProt names the protein GTPase ERas. Aliases and previous symbols include HRAS2 and HRASP. An earlier gene name was v-Ha-ras Harvey rat sarcoma viral oncogene homolog pseudogene.

Is ERAS linked to disease or conserved in other species?

NCBI Gene states that ERAS may be involved in cancer and chemotherapy resistance. The protein is not expressed in differentiated cells. A mouse ortholog, Eras, exists; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other Ras family GTPases and PI3K pathway components that are often studied alongside ERAS in stem cell and cancer research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q7Z444; product specifications from Assay Genie datasheets.

ERAS Product listing

There are no products listed under this category.